Health

CNN -  While grilling Novo Nordisk's chief executive over the price of its blockbuster diabetes and weight-loss drugs, Ozempic and Wegovy, Vermont Sen. Bernie Sanders alleged that 40,000 people a year in the US could die if the company doesn't make the medicines more affordable. It was the latest in a series of hearings Sanders has led with pharmaceutical company CEOs about the price of medicines in the US, which are higher — often by multiple times — than in other wealthy countries. Sanders noted that the list price for a four-week supply of Ozempic is $969 in the US, but the drug can be purchased for $155 in Canada and $59 in Germany. Similarly, Wegovy's list price is $1,349 in the US, but it's $186 in Denmark, $140 in Germany and $92 in the UK, he said.